Certified by Founder Lodge
F-Prime Capital
United States - Cambridge, MA
INVESTOR
1 Disclosed Funding Rounds $112,000,000
322 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management f
| Company | Date | Round | Raised |
|---|---|---|---|
 Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
 RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
 Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
 Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
 Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
 Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
